TipRanks
Swedish Orphan Biovitrum AB (DE:B6E)
FRANKFURT:B6E

Compare Swedish Orphan Biovitrum AB (B6E) vs. Competitors

5 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Swedish Orphan Biovitrum AB
€42.16
€13.45B
109.42
51.05%
4 Buy
0 Hold
0 Sell
Strong Buy
Hansa Biopharma AB
kr43.30
kr3.41B
-4.34
-20.17%
1 Buy
0 Hold
0 Sell
Moderate Buy
Medivir AB
kr1.72
kr1.02B
-4.24
5.42%
―
Orexo AB
kr13.54
kr480.52M
-1.56
-58.24%
―
Newbury Pharmaceuticals AB
kr2.48
kr70.22M
-2.71
-14.23%
―
Dicot Pharma AB
kr0.21
kr789.47M
-7.63
-69.92%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:B6E
Swedish Orphan Biovitrum AB
39.00
11.98
44.34%
SE:HNSA
Hansa Biopharma AB
34.12
-5.86
-14.66%
SE:MVIR
Medivir AB
1.59
0.15
10.08%
SE:ORX
Orexo AB
13.74
-21.26
-60.74%
SE:NEWBRY
Newbury Pharmaceuticals AB
2.23
-0.31
-12.20%
SE:DICOT
Dicot Pharma AB
0.23
-0.52
-69.72%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts